| Year |
Citation |
Score |
| 2022 |
Matloka M, Janowska S, Pankiewicz P, Kokhanovska S, Kos T, Hołuj M, Rutkowska-Wlodarczyk I, Abramski K, Janicka M, Jakubowski P, Świątkiewicz M, Welniak-Kaminska M, Hucz-Kalitowska J, Dera P, Bojarski L, et al. A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects. Frontiers in Pharmacology. 13: 999685. PMID 36438799 DOI: 10.3389/fphar.2022.999685 |
0.782 |
|
| 2021 |
Zajdel P, Grychowska K, Mogilski S, Kurczab R, Satała G, Bugno R, Kos T, Gołębiowska J, Malikowska-Racia N, Nikiforuk A, Chaumont-Dubel S, Bantreil X, Pawłowski M, Martinez J, Subra G, et al. Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT and 5-HT Receptor Antagonist with Antipsychotic and Procognitive Properties. Journal of Medicinal Chemistry. PMID 34467765 DOI: 10.1021/acs.jmedchem.1c00224 |
0.81 |
|
| 2019 |
Kozela E, Krawczyk M, Kos T, Juknat A, Vogel Z, Popik P. Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats. Molecular Neurobiology. PMID 31823199 DOI: 10.1007/S12035-019-01831-2 |
0.817 |
|
| 2018 |
Zajdel P, Kos T, Marciniec K, Satała G, Canale V, Kamiński K, Hołuj M, Lenda T, Koralewski R, Bednarski M, Nowiński L, Wójcikowski J, Daniel WA, Nikiforuk A, Nalepa I, et al. Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. European Journal of Medicinal Chemistry. 145: 790-804. PMID 29407591 DOI: 10.1016/J.Ejmech.2018.01.002 |
0.832 |
|
| 2017 |
Vanda D, Soural M, Canale V, Chaumont-Dubel S, Satała G, Kos T, Funk P, Fülöpová V, Lemrová B, Koczurkiewicz P, Pękala E, Bojarski AJ, Popik P, Marin P, Zajdel P. Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties. European Journal of Medicinal Chemistry. 144: 716-729. PMID 29291439 DOI: 10.1016/J.Ejmech.2017.12.053 |
0.705 |
|
| 2017 |
Popik P, Hołuj M, Kos T, Nowak G, Librowski T, Sałat K. Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents. Neurotoxicity Research. PMID 28577066 DOI: 10.1007/S12640-017-9759-0 |
0.813 |
|
| 2017 |
Zurawek D, Salerno-Kochan A, Dziedzicka-Wasylewska M, Nikiforuk A, Kos T, Popik P. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia. Schizophrenia Research. PMID 28433499 DOI: 10.1016/J.Schres.2017.04.014 |
0.769 |
|
| 2017 |
Canale V, Partyka A, Kurczab R, Krawczyk M, Kos T, Satała G, Kubica B, Jastrzębska-Więsek M, Wesołowska A, Bojarski AJ, Popik P, Zajdel P. Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. Bioorganic & Medicinal Chemistry. PMID 28391970 DOI: 10.1016/J.Bmc.2017.03.057 |
0.709 |
|
| 2017 |
Cieślak PE, Llamosas N, Kos T, Ugedo L, Jastrzębska K, Torrecilla M, Parkitna JR. The role of NMDA receptor-dependent activity of noradrenergic neurons in attention, impulsivity and exploratory behaviors. Genes, Brain, and Behavior. PMID 28383797 DOI: 10.1111/Gbb.12383 |
0.404 |
|
| 2016 |
Potasiewicz A, Hołuj M, Kos T, Popik P, Arias HR, Nikiforuk A. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats. Neuropharmacology. PMID 27717880 DOI: 10.1016/J.Neuropharm.2016.10.002 |
0.823 |
|
| 2016 |
Nikiforuk A, Potasiewicz A, Kos T, Popik P. The combination of memantine and galantamine improves cognition in rats: the synergistic role of the α7 nicotinic acetylcholine and NMDA receptors. Behavioural Brain Research. PMID 27435422 DOI: 10.1016/J.Bbr.2016.07.023 |
0.828 |
|
| 2016 |
Zajdel P, Marciniec K, Satała G, Canale V, Kos T, Partyka A, Jastrzębska-Więsek M, Wesołowska A, Basińska-Ziobroń A, Wójcikowski J, Daniel WA, Bojarski AJ, Popik P. N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties. Acs Medicinal Chemistry Letters. 7: 618-622. PMID 27326337 DOI: 10.1021/Acsmedchemlett.6B00056 |
0.693 |
|
| 2016 |
Grychowska K, Satała G, Kos T, Partyka A, Colacino E, Chaumont-Dubel S, Bantreil X, Wesołowska A, Pawlowski MH, Martinez J, Marin P, Subra G, Bojarski AJ, Lamaty F, Popik P, et al. Novel 1H-pyrrolo[3,2-c]quinoline based 5-HT6 receptor antagonists with potential application for the treatment of cognitive disorders associated with Alzheimer's disease. Acs Chemical Neuroscience. PMID 27100049 DOI: 10.1021/Acschemneuro.6B00090 |
0.707 |
|
| 2016 |
Nikiforuk A, Hołuj M, Kos T, Popik P. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia. Neuropharmacology. PMID 26826431 DOI: 10.1016/J.Neuropharm.2016.01.035 |
0.851 |
|
| 2015 |
Canale V, Kurczab R, Partyka A, Satała G, Słoczyńska K, Kos T, Jastrzębska-Więsek M, Siwek A, Pękala E, Bojarski AJ, Wesołowska A, Popik P, Zajdel P. N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT7 receptor selectivity versus multireceptor profile. Bioorganic & Medicinal Chemistry. PMID 26706111 DOI: 10.1016/J.Bmc.2015.11.041 |
0.67 |
|
| 2015 |
Potasiewicz A, Kos T, Ravazzini F, Puia G, Arias HR, Popik P, Nikiforuk A. Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor. British Journal of Pharmacology. 172: 5123-35. PMID 26276349 DOI: 10.1111/Bph.13277 |
0.817 |
|
| 2015 |
Nikiforuk A, Kos T, Hołuj M, Potasiewicz A, Popik P. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats. Neuropharmacology. 101: 389-400. PMID 26232639 DOI: 10.1016/J.Neuropharm.2015.07.034 |
0.824 |
|
| 2015 |
Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1300-13. PMID 26003081 DOI: 10.1016/J.Euroneuro.2015.04.018 |
0.843 |
|
| 2015 |
Skolnick P, Kos T, Czekaj J, Popik P. Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test. Acta Neuropsychiatrica. 27: 228-34. PMID 25858023 DOI: 10.1017/Neu.2015.14 |
0.713 |
|
| 2015 |
Popik P, Holuj M, Nikiforuk A, Kos T, Trullas R, Skolnick P. 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology. 232: 1025-38. PMID 25260339 DOI: 10.1007/S00213-014-3738-4 |
0.842 |
|
| 2015 |
Zajdel P, Canale V, Partyka A, Marciniec K, Kurczab R, Satała G, Siwek A, Jastrzębska-Więsek M, Wesołowska A, Kos T, Popik P, Bojarski AJ. Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7 receptor antagonists and their psychotropic properties Medchemcomm. 6: 1272-1277. DOI: 10.1039/C5Md00166H |
0.705 |
|
| 2015 |
Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats European Neuropsychopharmacology. 25: 1300-1313. DOI: 10.1016/j.euroneuro.2015.04.018 |
0.813 |
|
| 2014 |
Popik P, Kos T, Pluta H, Nikiforuk A, Rojek K, Ryguła R. Inhibition of the glucocorticoid synthesis reverses stress-induced decrease in rat's 50-kHz ultrasonic vocalizations. Behavioural Brain Research. 260: 53-7. PMID 24308957 DOI: 10.1016/J.Bbr.2013.11.029 |
0.697 |
|
| 2013 |
Nikiforuk A, Kos T, Fijał K, Hołuj M, Rafa D, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. Plos One. 8: e66695. PMID 23776692 DOI: 10.1371/Journal.Pone.0066695 |
0.832 |
|
| 2013 |
Nikiforuk A, Fijał K, Potasiewicz A, Popik P, Kos T. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats. Journal of Psychopharmacology (Oxford, England). 27: 469-76. PMID 23479455 DOI: 10.1177/0269881113480991 |
0.844 |
|
| 2011 |
Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P. Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner. Neuropharmacology. 61: 262-7. PMID 21530555 DOI: 10.1016/J.Neuropharm.2011.04.010 |
0.821 |
|
| 2011 |
Nikiforuk A, Kos T, Wesołowska A. The 5-HT6 receptor agonist EMD 386088 produces antidepressant and anxiolytic effects in rats after intrahippocampal administration. Psychopharmacology. 217: 411-8. PMID 21499701 DOI: 10.1007/S00213-011-2297-1 |
0.69 |
|
| 2011 |
Kos T, Nikiforuk A, Rafa D, Popik P. The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology. 214: 911-21. PMID 21161188 DOI: 10.1007/S00213-010-2102-6 |
0.817 |
|
| 2011 |
Popik P, Kos T, Zhang Y, Bisaga A. Memantine reduces consumption of highly palatable food in a rat model of binge eating. Amino Acids. 40: 477-85. PMID 20571841 DOI: 10.1007/S00726-010-0659-3 |
0.581 |
|
| 2008 |
Popik P, Kos T, Sowa-Kućma M, Nowak G. Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology. 198: 421-30. PMID 18458881 DOI: 10.1007/S00213-008-1158-Z |
0.625 |
|
| 2008 |
Bisaga A, Kos T, Wójcikowski J, Daniel WA, Popik P. Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice. Drug and Alcohol Dependence. 95: 147-51. PMID 18328640 DOI: 10.1016/J.Drugalcdep.2008.01.007 |
0.552 |
|
| 2007 |
Belozertseva IV, Kos T, Popik P, Danysz W, Bespalov AY. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 172-9. PMID 16630709 DOI: 10.1016/J.Euroneuro.2006.03.002 |
0.651 |
|
| 2006 |
Kos T, Legutko B, Danysz W, Samoriski G, Popik P. Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice. The Journal of Pharmacology and Experimental Therapeutics. 318: 1128-36. PMID 16740621 DOI: 10.1124/Jpet.106.103697 |
0.641 |
|
| 2006 |
Kos T, Popik P, Pietraszek M, Schäfer D, Danysz W, Dravolina O, Blokhina E, Galankin T, Bespalov AY. Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 297-310. PMID 16288851 DOI: 10.1016/J.Euroneuro.2005.10.001 |
0.7 |
|
| 2005 |
Kozela E, Wrobel M, Kos T, Wojcikowski J, Daniel WA, Wozniak KM, Slusher BS, Popik P. 2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice. Psychopharmacology. 183: 275-84. PMID 16220328 DOI: 10.1007/S00213-005-0182-5 |
0.75 |
|
| 2005 |
Popik P, Krawczyk M, Kos T, Nalepa I, Kowalska M, Witarski T, Antkiewicz-Michaluk L, Vetulani J. Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence. European Journal of Pharmacology. 515: 128-33. PMID 15893747 DOI: 10.1016/J.Ejphar.2005.04.009 |
0.613 |
|
| 2005 |
Kos T, Popik P. A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice. Behavioural Pharmacology. 16: 155-61. PMID 15864070 DOI: 10.1097/00008877-200505000-00004 |
0.628 |
|
| 2005 |
Popik P, Kos T, Pietraszek M, fer DS, Danysz W, Dravolina O, Blokhina E, Galankin T, Bespalov AY. B75 Effect Of 5-Ht3 Receptor Antagonist Mdl 72222 On Behaviors Induced By Ketamine In Rats And Mice Behavioural Pharmacology. 16. DOI: 10.1097/00008877-200509001-00280 |
0.646 |
|
| Show low-probability matches. |